Micro-scale blood plasma separation: from acoustophoresis to egg-beaters

M Kersaudy-Kerhoas, E Sollier - Lab on a Chip, 2013 - pubs.rsc.org
Plasma is a rich mine of various biomarkers including proteins, metabolites and circulating
nucleic acids. The diagnostic and therapeutic potential of these analytes has been quite …

Chances and challenges of new genetic screening technologies (NIPT) in prenatal medicine from a clinical perspective: a narrative review

I Bedei, A Wolter, A Weber, F Signore, R Axt-Fliedner - Genes, 2021 - mdpi.com
In 1959, 63 years after the death of John Langdon Down, Jérôme Lejeune discovered
trisomy 21 as the genetic reason for Down syndrome. Screening for Down syndrome has …

[HTML][HTML] A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital …

SE Norton, JM Lechner, T Williams, MR Fernando - Clinical biochemistry, 2013 - Elsevier
Objectives To study the ability of a stabilizing reagent to prevent cellular DNA contamination
of cell-free DNA (cfDNA) in plasma during whole blood sample storage and shipping …

Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia

AN Barrett, TCR McDonnell, KCA Chan… - Clinical …, 2012 - academic.oup.com
BACKGROUND Cell-free fetal DNA (cffDNA) constitutes approximately 10% of the cell-free
DNA in maternal plasma and is a suitable source of fetal genetic material for noninvasive …

Non‐invasive prenatal determination of fetal sex: translating research into clinical practice

M Hill, K Finning, P Martin, J Hogg, C Meaney… - Clinical …, 2011 - Wiley Online Library
Hill M, Finning K, Martin P, Hogg J, Meaney C, Norbury G, Daniels G, Chitty LS. Non‐
invasive prenatal determination of fetal sex: translating research into clinical practice. The …

Implementing prenatal diagnosis based on cell-free fetal DNA: accurate identification of factors affecting fetal DNA yield

AN Barrett, BG Zimmermann, D Wang, A Holloway… - PloS one, 2011 - journals.plos.org
Objective Cell-free fetal DNA is a source of fetal genetic material that can be used for non-
invasive prenatal diagnosis. Usually constituting less than 10% of the total cell free DNA in …

PREIMPLANTATION GENETIC TESTING: Non-invasive prenatal testing for aneuploidy, copy-number variants and single-gene disorders

J Shaw, E Scotchman, N Chandler, LS Chitty - Reproduction, 2020 - rep.bioscientifica.com
The discovery of cell-free fetal DNA (cffDNA) in maternal plasma has enabled a paradigm
shift in prenatal testing, allowing for safer, earlier detection of genetic conditions of the fetus …

Cell-free fetal DNA and RNA in maternal blood: implications for safer antenatal testing

CF Wright, LS Chitty - BMJ, 2009 - bmj.com
Cell-free fetal DNA and RNA in maternal blood: implications for safer antenatal testing | The
BMJ Skip to main content Intended for healthcare professionals Access provided by Google …

Reliability of fetal sex determination using maternal plasma

PG Scheffer, CE van der Schoot… - Obstetrics & …, 2010 - journals.lww.com
OBJECTIVE: To determine the diagnostic accuracy of noninvasive fetal sex determination in
maternal plasma. METHODS: All consecutive patients for whom fetal sex determination in …

Cell-free fetal DNA testing for prenatal diagnosis

S Drury, M Hill, LS Chitty - Advances in clinical chemistry, 2016 - Elsevier
Prenatal diagnosis and screening have undergone rapid development in recent years, with
advances in molecular technology driving the change. Noninvasive prenatal testing (NIPT) …